Osteoporosis

Denosumab Superior to Ibandronate at Increasing Bone Mineral Density in Osteoporosis

By

Rheumatology Advisor Contributing Writer

Researchers evaluated the effects of ibandronate and denosumab on bone mineral density following romosozumab therapy in women with postmenopausal osteoporosis.

Resistance Training May Improve Bone Health for Vegans

Bone microarchitecture differs for vegans versus omnivores, but these differences are attenuated for participants reporting resistance training.

Vitamin D Supplement Does Not Reduce Fracture Risk in Older Adults

Among adults not selected for vitamin D deficiency, low bone mass, or osteoporosis, no effect seen on total, nonvertebral, or hip fracture risk

Fracture Risk Increased With Insulin Compared With Metformin in T2D

For patients with type 2 diabetes, fracture risk is increased with insulin use compared with metformin use.

Effect of Weight Training on Symbol Digit Modality Test Scores in MS

Presenting at CMSC 2022, researchers investigated the effects of weight training on bone density, quality of life, and cognition in patients with MS.

Fracture Risk in CKD Not Higher With SGLT2 Inhibitors

Patients with CKD are vulnerable to fractures due to CKD mineral bone disorder.

Spinal Anesthesia Linked to More Severe Pain After Hip Fracture Surgery

Severe pain is common after hip fracture surgery, and spinal anesthesia is associated with greater pain in the first 24 hours after surgery.

Deep-Radiomics Models Can Diagnose Osteoporosis

A deep-radiomics approach can be used to diagnose osteoporosis from hip radiographs.

SGLT2 Inhibitor Use Not Linked to Increased Fracture Risk in CKD

For older adults, initiation of a SGLT2 inhibitor is not associated with higher fracture risk compared with initiation of a DPP-4 inhibitor.

Effect of Levothyroxine on Bone Health in Subclinical Hypothyroidism

Researchers assessed the effect of thyroid hormone replacement therapy with levothyroxine on bone health among older patients with subclinical hypothyroidism.

Gentamicin-Eluting Bone Graft Substitute Gets FDA Clearance

Cerament G is a resorbable, gentamicin-eluting ceramic bone void filler.